Breaking News

Sun Pharma, Rockwell Medical Enter Licensing and Supply Pact

Sun Pharma will be the exclusive development and commercialization partner for Rockwell's Triferic

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Sun Pharmaceutical Industries’ subsidiary has entered into exclusive licensing and supply agreements with Rockwell Medical Inc. to commercialize Rockwell’s Triferic, a proprietary iron replacement and haemoglobin maintenance drug, for treating anaemia in hemodialysis patients in India. Triferic is approved in USA. Sun Pharma will be the exclusive development and commercialization partner for Triferic during the term of the agreement. In consideration for the license, Rockwell will be e...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters